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Abstract
Background: The influence of the pharmaceutical industry and other stakeholders on medical
science has been increasingly criticised. When dealing with conflicts of interest in scientific
publications it is important to ensure the best possible transparency. The objective of this work is
to examine the disclosure practice of financial and non-financial conflicts of interest in German
language publications concerning health services research for the first time.
Methods: We performed a systematic literature search in the PubMed data base using the MeSH
term "health services research". The review was conducted on July 10, 2006, setting the limits
"dates: published in the last 2 years" and "languages: German" (only articles with abstracts). 124
articles in 31 magazines were found. In the magazines the instructions for authors were examined
as to whether a statement on conflicts of interest is expected – and if, in which form. Regarding
the articles in the journals which require a statement, we examined whether the statement is
explicitly published. The results are descriptively represented.
Results: 13 magazines (42%) do not require any statement on conflicts of interest, whereas 18
journals (58%) expect a statement. Two of these 18 magazines refer explicitly to the uniform
requirements of the International Committee of the Medical Journal Editors (ICMJE); the remaining 16
magazines give differently accentuated instructions on how to disclose conflicts of interest,
whereby the focus is primarily on financial issues. A statement on conflicts of interest is explicitly
published in 11 of the 71 articles (15%) which are found in the magazines that require a statement
with the submission of a manuscript. Related to the total number of included articles, this means
that the reader explicitly receives information on potential conflicts of interest in 9% of the cases
(11 of 124 articles). Statements of others that are involved in the publication process (reviewers,
editors) are not available in any of the articles examined.
Conclusion:  A better sensitization for possible conflicts of interest in German publications
concerning health services research is necessary. We suggest tightening the criteria for disclosure
in the instructions for authors in the scientific journals. Among other things the equivalent
consideration of financial and non-financial conflicts of interest as well as the obligatory publication
of the statements should be part of good practice.
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Background
The influence of industry on medical sciences has been
increasingly criticised [1,2]. One reason is that studies
sponsored by the industry much more frequently produce
positive results for products of the sponsor, compared to
studies that are not sponsored by the industry [3,4]. For
example, data exist which show that statements on cost
effectiveness of diagnostic or therapeutic procedures are
more frequently favourable if the investigations are spon-
sored by the industry [5]. The transfer of scientific exper-
tise to clinical practice may be affected by the relationship
between the authors of clinical practice guidelines and the
pharmaceutical industry: four out of five authors have
connections to the pharmaceutical industry, and two of
these four are close advisors or employees of the compa-
nies which drugs they recommend in the guidelines [6].
This – more or less pronounced – proximity of scientists
to the industry is reflected in the scientific magazines as is
exemplarily highlighted by the statement of a former edi-
tor of the New England Journal of Medicine: one rarely finds
psychiatrists for editorials on the treatment of depression
who have no financial connections to the pharmaceutical
industry [2,7].
A conference on "disease mongering" in 2006 [8] illus-
trates the importance of the topic for health services
research. Among other things, it becomes clear that the
interests of third parties can aim at the opening or exten-
sion of a market for a product or a service. For example the
strategies can consist of the redefinition of limits and
treatment objectives as well as of the influence on the
public view in respect to the appropriateness of medical
services; strategies that were already described by the
American author Payer almost 25 years ago [9].
Standards for disclosing conflicts of interest
An important instrument in dealing with conflicts of
interest scientifically is ensuring best possible transpar-
ency [5]. Internationally accepted standards for this are set
by the Uniform Requirements for Manuscripts Submitted to
Biomedical Journals by the International Committee of
Medical Journal Editors (ICMJE). Apart from financial
interest, problems that may result from non-financial con-
flicts of interest are explicitly mentioned [10]:
" [...] Conflict of interest exists when an author (or the
author's institution), reviewer, or editor has financial or
personal relationships that inappropriately influence
(bias) his or her actions (such relationships are also
known as dual commitments, competing interests, or
competing loyalties). These relationships vary from those
with negligible potential to those with great potential to
influence judgment, and not all relationships represent
true conflict of interest. The potential for conflict of inter-
est can exist whether or not an individual believes that the
relationship affects his or her scientific judgment. Finan-
cial relationships, (such as employment, consultancies,
stock ownership, honoraria, paid expert testimony) are
the most easily identifiable conflicts of interest and the
most likely to undermine the credibility of the journal, the
authors, and of science itself. However, conflicts can occur
for other reasons, such as personal relationships, aca-
demic competition, and intellectual passion. All partici-
pants in the peer review and publication process must
disclose all relationship that could be viewed as present-
ing a potential conflict of interest. [...]".
Lack of or incomplete disclosure of potential conflicts of
interest prevent the reader from applying the appropriate
scepticism in the scientific dialogue [11].
Research question
There have been no studies so far on the disclosure prac-
tice of conflicts of interest in scientific journals within the
field of health services research. Therefore, the objective of
this study is to examine the current practice using the
example of German language journals. In particular, the
following research questions should be investigated:
▪ What criteria are set up for the disclosure of conflicts of
interests in the instructions for authors?
▪ How transparent is the practice of disclosure for the read-
ers?
Health services research in Germany
Internationally, health services research in Germany1 is in
an early stage of development. However, it has increas-
ingly received attention and support especially within the
last few years. Milestones are, for example, the research
programs by the Federal Ministry for Education and
Research (BMBF) and the compulsory health insurance
funds in the year 2000 and the strategies to promote
research by the German Medical Association (Bundesaer-
ztekammer) in 2005. Quite recently Pfaff und Kaiser, who
are well-known experts in this area, looked critically at the
situation of health services research in Germany [12].
They state that research activities are characterized by a
concentration on topics guided by special interests of
stakeholders. The authors attribute this to the high pro-
portion of commissioned research aiming at fast, practical
usability and threatening the scientific soundness of
health services research.
Methods
To identify both articles and journals, a systematic litera-
ture search was conducted in the PubMed data base using
the MeSH term "health services research" as well as the
free terms "health system research" and "health research"BMC Health Services Research 2007, 7:78 http://www.biomedcentral.com/1472-6963/7/78
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which are also in use within the field of interest in Ger-
many. The review was conducted on July 10, 2006, setting
the defined PubMed limits "dates: published in the last 2
years" and "languages: German". Only articles with
abstracts were included.
124 articles in 31 different journals were found (table 1,
see Additional file 1). Most contributions (23%) originate
from Bundesgesundheitsblatt, followed by Das Gesundheits-
wesen (11%) and Psychiatrische Praxis (10%).
Analysis of the journals
The instructions for authors were examined in all 31 jour-
nals using the freely accessible internet homepages of the
journals (all accesses on July 10, 2006):
▪ Is a statement on conflicts of interest demanded?
▪ If so, do the instructions refer to the criteria of the Inter-
national Committee of Medical Journal Editors (ICMJE
criteria)?
▪ If they do not refer to the ICMJE criteria, which other cri-
teria are applied?
Analysis of the articles
Of the articles published in magazines which require an
authors' statement on conflicts of interest (n = 71), we
examined the following questions using full text articles:
▪ Is the statement explicitly published? We considered a
statement as explicitly published if it was presented in the
form of a specific paragraph with an explicit title "conflicts
of interest" or likewise. We did not consider a statement as
explicitly published if information on conflicts of interest
could be gained from, e.g., the acknowledgement or
unspecificly titled paragraphs (e.g. "annotations").
▪ If the statement is explicitly published, what kind of
information is presented in the text?
▪ Are statements on conflicts of interest available from
others who are essentially involved in the publication
process (reviewers, editors)?
All articles (with and without explicit statements of con-
flicts of interest; differentiated in the tables 2 and 3, see
Additional file 1) were examined as to whether informa-
tion on possible conflicts of interest could be deducted
from the institutional affiliations of the authors (e.g. staff
members of for-profit companies) and from the acknowl-
edgements.
Furthermore we wanted to gather information about the
relevance of pharmaceutical topics within the included
publications, since these topics are particularly important
in respect to the research questions. For this purpose the
titles and the summaries of all 124 articles were qualita-
tively analysed: does the article particularly deal with
pharmaceutical topics?
The analyses of both the articles and the journals were per-
formed by the principal investigator (NSCH) and the co-
author (HL) independently from each other. A medical
data assistant crossed-checked the findings. In case of dif-
ferent assessments the investigators came to a decision by
consensus.
Results
Of the included journals, 18 (58%) require an authors'
statement on conflicts of interest, 13 (42%) do not require
a statement (table 1, see Additional file 1). Of the 18 mag-
azines which require a statement,
▪ two journals explicitly refer to the ICMJE criteria (Psychi-
atrische Praxis und Wiener Klinische Wochenschrift);
▪ 16 journals provide differently accentuated instructions
on how to disclose conflicts of interest, whereby three of
these journals exlusively focus on financial conflicts of
interest, (Zeitschrift für Orthopaedie und ihre Grenzgebiete,
Deutsche Medizinische Wochenschrift, Fortschritt in der Neu-
rologie-Psychiatrie). The remaining 13 journals include the
issue of non-financial conflicts of interest in different
ways, e.g. by phrases like "activities of a participant" or
"organizational support".
71 articles are published in the 18 journals which require
an authors' disclosure on conflict of interest (table 2, see
Additional file 1). In 11 of these articles (15%) we found
explicit publication of the statements; these articles are
from following journals: Deutsche Medizinische Wochen-
schrift (n = 3), HNO, Der Unfallchirurg, Der Schmerz, Der
Anaesthesist, Der Orthopaede, Der Hautarzt, Der Internist,
Der Nervenarzt (in each case n = 1). Related to the total
number of included articles, this means that the readers
are informed of potential conflicts of interest in 9% of the
cases (11 of 124 articles), independently of whether or
not conflicts of interest exist. In 10 of the 11 statements no
conflicts of interest are declared, (articles no. 4, 19, 26, 30,
33, 36, 40, 46, 64, 65). In a contribution to Deutsche
Medizinische Wochenschrift it is indicated that the investi-
gation was planned and evaluated by a drug company,
and that the authors are staff members of this company
(no. 22).
In five articles, topically relevant information can be
gained from the institutional affiliation of the authors and
the acknowledgements and annotations respectively:BMC Health Services Research 2007, 7:78 http://www.biomedcentral.com/1472-6963/7/78
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▪ Himmel et al. point out that they received allowance
from a pharmaceutical company for a part of their work;
however, an influence on the study was ruled out by con-
tract (article no. 29);
▪ the author of article no. 85 is director of a pharmaceuti-
cal company;
▪ two of ten authors of article no. 88 are staff members of
a pharmaceutical company;
▪ Morgenroth et al. thank a pharmaceutical company for
its support (no. 102);
▪ in article no 35 the authors declared no conflicts of inter-
est in a paragraph titled "annotation"; however, this does
not fulfill our critera for an explicit statement.
In none of the examined articles statements on conflicts of
interests of others that are involved in the publication
process (reviewers, editors) could be found.
As far as is recognizable from the titles and summaries,
pharmaceutical topics are particularly dealt with in 26 of
the 124 articles (21%). In less than a third of these articles
information on conflicts of interest could be found, (8 of
26 articles: no. 22, 29, 33, 46, 56, 85, 88, 102), partly in
the form of explicit disclosures and partly in the form of
acknowledgements and the authors' institutional affilia-
tions.
Discussion
For the first time, this study examines the disclosure prac-
tice of conflicts of interest in German language publica-
tions on health services research. Some limitations need
to be discussed. We confined our search to the PubMed
data base. Therefore the results are limited by the fact that
some journals which were not listed in PubMed at the
date of search – but which could also be relevant in this
context – were not included: for example, Zeitschrift für
Allgemeinmedizin that has a high portion of articles on
health services research and which publishers are known
to be intensively engaged in the topic of conflicts of inter-
ests [13]. However, we assume that our findings would
not significantly differ if we had used further data bases.
Furthermore, no English language articles were included,
thus the data are not representative for all publications on
health services research from Germany. However, it is
assumed that the scientific debate on health services
research topics in Germany has so far significantly taken
place in German language journals.
Little transparency
Overall, the sensitivity for the problem of conflicts of
interest seems to be in need of improvement in the circle
of the examined journals. Only about half of the journals
expect statements from authors on conflicts of interest –
and only in a few cases is the reader explicitly informed
about the statements. Whether the received statements are
published with the articles is in the responsibility of the
editors, sometimes in agreement with the authors.
The transparency would be greater if the statements were
published on principle, independently whether conflicts
of interest are declared or not. This procedure would give
the reader the chance to develop an unfiltered opinion
about possible conflicts of interest; furthermore, this pro-
cedure could be suitable to increasing the sensitivity for
the problem of all parties involved (authors, editors,
reviewers, readers). Information on possible conflicts of
interest of reviewers and editors are not available in any of
the articles, although this could also be considered as
good scientific practice [10]. Particularly little is known
about editors' conflicts of interest and how to manage this
problem [14].
Insufficient consideration of non-financial conflicts of 
interest
Another critical issue is the understanding of conflicts of
interest. The fact that they can result from direct financial
allowances is comparatively self-evident. However, the
various other causes for possible conflicts of interest are
easily underestimated [11]. Thus the International Com-
mittee of Medical Journal Editors (ICMJE) describes the
characteristics of non-financial interest conflicts in detail
[10].
Of the German language journals included in this study,
only two journals explicitly refer to the "uniform require-
ments for manuscripts submitted to biomedical journals".
In the instructions for authors in the remaining 29 jour-
nals the topic of non-financial conflicts of interest is in no
case dealt with as elaborately as the ICMJE criteria suggest.
Instead, non-financial conflicts of interest are addressed
in a very general way, and partially completely left blank.
The three journals with the most contributions on health
services research in this study proceed differently (see
table 1, see Additional file 1): Bundesgesundheitsblatt
demands statements on conflicts of interest from the par-
ticipants of the publication process (explicitly mentioned:
authors, editors, reviewers), whereby financial aspects are
addressed clearly and non-financial rather generally
("activities"). However, information on the statements is
available only in one of the examined cases, in form of an
acknowledgement (article no. 29). For the reader, this
could mean that in all other cases no conflicts of interestBMC Health Services Research 2007, 7:78 http://www.biomedcentral.com/1472-6963/7/78
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were declared; it could also mean that conflicts of interest
were declared but the responsible persons did not see the
necessity to publish the statements. However, the reader-
ship has no chance to form an unfiltered opinion.
The journal Das Gesundheitswesen provides no informa-
tion at all on the disclosure of conflicts of interest in its
instructions for authors. Psychiatrische Praxis is one of the
two journals which explicitly refer to the ICMJE criteria.
However, in none of the 13 articles examined are the state-
ments presented to the readership.
Ambiguity of the understanding of conflicts of interest
The extent of ambiguity on the question of which issues
should be declared as possible conflicts of interest may be
illustrated by an example outside of the focus of this
study. In the Journal of the American Medical Association,
Kurt et al. published an article on "Migraine and risk of
cardiovascular disease in women"; the authors declared
that they have no relevant conflicts of interest [15].
In fact, the authors have numerous connections to phar-
maceutical companies which sell products for the treat-
ment of migraine and cardiovascular diseases, as Kurt et
al. had to reveal later in a letter to the publishers. The
authors state that they assumed that in the case of the arti-
cle these connections are not conflicts of interest. They
close with the sentence: "We have learned that it is best to
disclose all relationships with for-profit companies and
allow the editor(s) to decide what is relevant"[16]. In the
editorial it is pointed out clearly that the editors of JAMA
expect the disclosure of all possible conflicts of interest
[17].
From the fact that only a fifth of the articles in our study
deal with pharmaceutical topics in a closer or wider sense,
it should not be concluded that conflicts of interest which
may result from the influence of for-profit companies are
less important in health services research than, e.g., in
medical research. Besides the pharmaceutical industry,
other for-profit companies could influence science, for
example companies that sell technical equipment [18].
Furthermore, within the health system the influence on
science of social insurance institutions, political institu-
tions, various associations and numerous lobby groups
has to be critically reflected – in particular against the
background of the high proportion of commissioned
studies that characterize health services research in Ger-
many [12].
As in no other discipline health services research is con-
cerned with the framework requirements of health care on
different levels of the system. Thereby, various stakehold-
ers could be very interested in using health services
research to shape specific issues within the health care sys-
tem in their favour. For example, one should reflect on the
phenomenon of "disease mongering" which can be
described as the attempt to define the population which
allegedly suffers from a certain disease as large as possible
and to extend the need for medical care [9]. A quotation
from a critical editorial in Zeitschrift für Allgemeinmedizin
makes clear how attentive health services research should
be designed to avoid being used for the objectives of third
parties: "develop a topic field, and prove that there is
undersupply; everything else finds itself" [13].
Implications for health services research in Germany
Pfaff and Kaiser recommend for future health services
research in Germany that topics not in the immediate
interest of financially potent stakeholders should specifi-
cally be promoted by the state [12]. Our data suggest that
it is necessary to increase the transparency in the practice
of scientific publication, not only related to direct finan-
cial allowances but also related to non-financial conflicts
of interest. The "uniform requirements for manuscripts
submitted to biomedical journals" [10] provide a good
orientation for its realisation.
It is important that the claim for disclosure of all possible
conflicts of interest contains no allegation against authors,
editors or reviewers. An explicit comment seems to be use-
ful at this point, e.g. as it is done in the instructions for
authors of the journal Der Nervenarzt (table 1, see Addi-
tional file 1).
However, even if the disclosure practice is optimised,
achieving full transparency in scientific publication is not
a realistic ambition. In her editorial on the influence of
money on science, DeAngelis outlined the problem as fol-
lows [1]: "There is simply no way to guarantee that all
financial relationships and arrangements of all authors
are disclosed. It is not feasible to independently investi-
gate the financial relationships of every author, as no
comprehensive, up-to-date source of this information
exists". Finally the appeal for honesty remains the elemen-
tary component of good science.
Conclusion
The study points out that a better sensitization for possi-
ble conflicts of interest in health services research is neces-
sary. We suggest tightening the criteria for disclosure in
the instructions for authors in the scientific journals.
Among other things, this means
▪ similar consideration of financial and non-financial
interest conflicts;
▪ obligatory publication of the statements to provide the
readers with unfiltered information, independently of
whether conflicts of interest are stated or not;Publish with BioMed Central    and   every 
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▪ application of this procedure to authors, reviewers and
editors.
This strategy should be applied on all types of publica-
tions independent of their topics.
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Appendix
1 Our definition of health services research refers to the
statement of the Zentrum für Versorgungsforschung (Centre
of Health Services Research), Cologne, Germany [19].
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